GenMark Diagnostics: 4Q Earnings Snapshot
CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Thursday reported a loss of...
Source: sfgate.com
Page 12 - Mark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Diagnostics Today - Breaking & Trending Today
iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Concert Pharmaceuticals Inc (NASDAQ: CNCE) (before the market open) Kala Pharmaceuticals Inc (NASDAQ: KALA) (before the market open) Jounce Therapeutics Inc (NASDAQ: JNCE) (before the market open) Intellia Therapeutics Inc (NASDAQ: NTLA) (before the market open) Moderna Inc (NASDAQ: MRNA) (before the market open) Radius Health Inc (NASDAQ: RDUS) (before the market open) Insmed Incorporated (NASDAQ: INSM) (before the market open) Intercept Pharmaceuticals Inc (NASDAQ: ICPT) (before the market open) Editas Medicine Inc (NASDAQ: EDIT) (before the market open) Mediwound Ltd (NASDAQ: MDWD) (before...
Source: benzinga.com
Investegate |GenMark Diagnostics, Inc. Announcements | GenMark Diagnostics, Inc.: Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the publication of a manuscript in Frontiers in Cellular and Infection Microbiology that highlights strong performance and the potential clinical impact of the ePlex Blood Culture Ident...
Source: investegate.co.uk
BioMark Diagnostics, Inc.: BioMark and Phytronix Technologies Inc. Enter into a Collaborative Research and Development Agreement
(1) Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. has entered into a collaborative research and development agreement with Phytronix Technologies Inc. ("Phytronix") to advance the development of BioMark's early lung cancer screening applications using Phytronix-proprietary Laser Diode Thermal Desorption (LDTD) technology. While BioMark Diagnostic Solutions is preparing to offer lab services and metabolomics...
Source: finanznachrichten.de
(ANCN), (APHA) - 12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Ayala Pharmaceuticals (NASDAQ:AYLA) shares rose 61.99% to $21.06 during Thursday's regular session. The current volume of 576.7K shares is ...
Source: benzinga.com